Yue Song
机构：Merck & Co., Inc., Rahway, NJ, USA (United States), Beijing Anzhen Hospital, Seventh People's Hospital of Shanghai · ORCID：0000-0003-0898-5281
发表论文 79 篇 · 总被引 941 次 · h-index 17
代表论文
- Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma (2024 · Annals of Oncology · 被引 81)
- LITESPARK-012: Pembrolizumab Plus Lenvatinib With or Without Belzutifan or Quavonlimab for Advanced Renal Cell Carcinoma (2023 · Future Oncology · 被引 31)
- Role of gut microbiota in neuroinflammation: a focus on perioperative neurocognitive disorders (2025 · Frontiers in Cellular and Infection Microbiology · 被引 11)
- Fangchinoline-mediated autophagy inhibition amplifies antigen presentation and PD-1 blockade efficacy in lung cancer (2025 · Acta Pharmacologica Sinica · 被引 8)
- Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis (2024 · Blood Cancer Journal · 被引 7)
- Low-dose emapalumab combined with chemotherapy for adult patients with Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis (2024 · Transplant Immunology · 被引 6)